Phase 2, Randomized, Double-blind Study to Evaluate Immunogenicity Superiority of a Booster Dose With an Omicron or a Trivalent Vaccine Compared to CoronaVac, in Adults Immunized With Different Vaccine Schedules Against SARS-CoV-2 in Chile
Latest Information Update: 13 Feb 2024
At a glance
- Drugs SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms CoronaVarCL
- 05 Feb 2024 Status changed from recruiting to completed.
- 12 Jan 2023 Status changed from not yet recruiting to recruiting.
- 07 Sep 2022 New trial record